Mechanisms of premature ovarian failure: Reappraisal and overview

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 7, 2007, Pages 623-629

  Mahmoud, Mohamad S ^b   Merhi, Zaher O ^a   Yelian, Frank D ^b  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b NONE

Author keywords

Autoimmune diseases; Chromosomal aberrations; Mutation; Premature ovarian failure

Indexed keywords

FOLLITROPIN RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ADRENAL INSUFFICIENCY; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CHROMOSOME ABERRATION; FEMALE; FRAGILE X SYNDROME; GALACTOSEMIA; GENE MUTATION; HUMAN; HYPOTHYROIDISM; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; THYROID DISEASE; TURNER SYNDROME;

ADULT; AUTOIMMUNE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IATROGENIC DISEASE; MUTATION; OVARIAN FAILURE, PREMATURE; SEX CHROMOSOME DISORDERS;

EID: 34547106583     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Gold EB, Bromberger J, Crawford S, et al: Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-874
2. Santoro N: Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) 2003;64:87-92
3. Speroff L, Glass RH, Kase NG: Clinical Gynecologic Endocrinology and Infertility. Sixth edition. Baltimore, Lippincott Williams & Wilkins, 1999, pp 446-447
4. Alper MM, Garner PR: Premature ovarian failure: Its relationship to autoimmune disease. Obstet Gynecol 1985;66:27-30
5. Van Noord PA, Dubas JS, Dorland M, et al: Age at natural menopause in a population based screening cohort: The role of menarche. Fertil Steril 1997;68:95-102
6. O'Connor KA, Holman DJ, Wood JW: Declining fecundity and ovarian aging in natural fertility populations. Maturitas 1998;30:127-136
7. Nikolaou D, Lavery S, Turner C, et al: Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 2002;17:1106-1111
8. Nikolaou D, Trew G: Contribution of assisted reproductive technology to the understanding of early ovarian ageing. In The Management of the Menopause. Third edition. Edited by J Studd. London, Parthenon Publishing, 2003, pp 185-198
9. Nikolaou D, Templeton A: Early ovarian ageing: A hypothesis, detection and clinical relevance. Hum Reprod 2003;18: 1137-1139
10. Conway GS: Premature ovarian failure. Curr Opin Obstet Gynecol 1997;9:202-206
11. McDonough PG, Byrd JR, Tho PT, et al: Phenotypic and cytogenetic findings in eighty-two patients with ovarian failure: Changing trends. Fertil Steril 1977;28:638-641
12. Harlow BL, Cramer DW, Annis KM: Association of medically treated depression and age at natural menopause. Am J Epidemiol 1995;141:1170-1176
13. Bahner F, Schwarz G, Hienz HA, et al: Turner syndrome: Mit Voll Ausgebilden Sekundaren Geschlechtsmerkmalen Une fertilitat. Acta Endocrinol 1960;35:397-404
14. Singh DN, Hara S, Foster HW, et al: Reproductive performance in women with sex chromosome mosaicism. Obstet Gynecol 1980;55:508-611
15. Krauss CM, Turksoy RN, Atkins L, et al: Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987;317:125-131
16. Dewhurst J: Fertility in 47,XXX and 45,X patients. J Med Genet 1978;15:132-135
17. Machado-Ferreira C, Costa-Lima MA, Boy RT, et al: Premature ovarian failure and FRAXA premutation: Positive correlation in a Brazilian survey. Am J Med Genet 2004;126:237-240
18. Gersak K, Meden-Vrtovec H, Peterlin B: Fragile X premutation in women with sporadic premature ovarian failure in Slovenia. Hum Reprod 2003;18:1637-1640
19. Bussani C, Papi L, Sestini R, et al: Premature ovarian failure and fragile X premutation: A study on 45 women. Eur J Obstet Gynecol Reprod Biol 2004;112:189-191
20. Sato K, Uehara S, Hashiyada M, et al: Genetic significance of skewed X-chromosome inactivation in premature ovarian failure. Am J Med Genet A 2004;130:240-244
21. Harris SE, Chand AL, Winship IM, et al: Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 2002;8:729-733
22. Yan C, Matzuk MM: Transgenic models of ovarian failure. J Soc Gynecol Invest 2001;8:530-533
23. Dixit H, Deendayal M, Singh L: Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 2004;19:1760-1764
24. Leegwater PA, Vermeulen G, Konst AA, et al: Subunits of the translation initiation factor EiF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 2001;29:383-388
25. Fogli A, Rodriguez D, Eymard-Pierre E, et al: Ovarian failure and EIF2B mutations. Am J Hum Genet 2003;72:1544-1550
26. Uda M, Ottolenghi C, Crisponi L, et al: Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 2004;13:1171-1181
27. Waggoner DD, Buist NRM, Donnell G: Long term prognosis in galactosemia: Results of a survey of 350 cases. J Inher Metab Dis 1990;13:802-818
28. Twigg S, Wallman L, Mcelduff A: The resistant ovary syndrome in a patient with galactosemia: A clue to the natural history of ovarian failure. J Clin Endocrinol Metab 1996;81: 1329-1331
29. Levy HL, Driscoll SG, Porensky RS, et al: Ovarian failure in galactosemia. N Engl J Med 1984;5:310-350
30. Kaufmann FR, Kogut MD, Donell GN, et al: hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304:994-998
31. Forges T, Monnier-Barbarino P: Premature ovarian failure in galactosaemia: Pathophysiology and clinical management. Pathol Biol (Paris) 2003;51:47-56 (in French)
32. Da Fonte Kohek MB, Batista MC, Russell AJ, et al: No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertil Steril 1998;70:565-567
33. Takakura K, Takebayashi K, Wang HQ, et al: Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 2001;75:207-209
34. Zhao XX, Suzumori N, Yamaguchi M, et al: Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure. Fertil Steril 2005;83:1843-1844
35. Forges T, Monnier-Barbarino P, Faure GC, et al: Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004;10:163-175
36. Nelson LM, Covington SN, Rebar RW: An update: Spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005;83:1327-1332
37. Goswami R, Goswami D, Kabra M, et al: Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril 2003;80:1052-1054
38. Chiauzzi VA, Bussmann L, Calvo JC, et al: Circulating immunoglobulins that inhibit the binding of follicle-stimulating hormone to its receptor: A putative diagnostic role in resistant ovary syndrome? Clin Endocrinol 2004;61:46-54
39. Larsen EC, Muller J, Schmiegelo K, et al: Reduced ovarian function in long-term survivor of radiation and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003;88: 5307-5314
40. McKinlay SM: The normal menopause transition: An overview. Maturitas 1996;26:137-145
41. Cooper GS, Hulka BS, Baird DD, et al: Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age. Fertil Steril 1994; 62:1168-1175
42. Harlow BL, Cramer DW, Annis KM: Association of medically treated depression and age at natural menopause. Am J Epidemiol 1995;141:1170-1176
43. Progetto Menopausa Italia Study Group: Premature ovarian failure: Frequency and risk factors among women attending a network of menopause clinics in Italy. Br J Obstet Gynaecol 2003;110:59-63
44. Giltay JC, Ausems MG, van Seumeren I, et al: Short stature as the only presenting feature in a patient with isodicentric (Y)(q11.23) and gonadoblastoma: A clinical and molecular cytogenic study. Eur J Pediatr 2001;160:154-158
45. Nelson L: Autoimmune ovarian failure: Comparing the mouse model and the human disease. J Soc Gynecol Invest 2001;8:55-57
46. Myhre A, Halonen M, Eskelin P, et al: Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol (Oxf) 2001;54:211-217
47. Groff AA, Covington SN, Halverson LR, et al: Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005;83:1734-1741